There are over 13,000 women diagnosed with cervical cancer each year in the United States alone. In fact, even with early detection, it is estimated that there will be 13,240 new cases of invasive cervical cancer detected in 2018. In the past, cervical cancer was a leading cause of death for American women, however, it can now be prevented with the use of the Pap Smear and the HPV vaccination. Cervical cancer generally occurs in middle aged women, but it can still present itself in younger or older women who have not been screened regularly.
For years, attempts have been made to understand the mechanism behind the proliferation of cancer cells: they need metabolites to grow and proliferate as much as a vehicle needs gasoline or electricity to move. However, until now it was not known which metabolites cancer cells actually need. Medical researchers have now identified one of the mechanisms behind this process.
Researchers from Bosnia and Herzegovina, the US, and Qatar tracked down potential protein markers for treatment response or resistance in olfactory neuroblastoma during a multi-omics analysis of the rare nasal cancer.
Dr. William F. Regine is chair of radiation oncology at the University of Maryland School of Medicine. He and Cedric Yu, a clinical professor of radiation oncology at the university, created the GammaPod machine, which delivers strong doses of radiation more precisely to tumors.